The improved everted gut sac: a simple method to study intestinal P-glycoprotein

被引:91
作者
Barthe, L
Bessouet, M
Woodley, JF
Houin, G [1 ]
机构
[1] CHU Rangueil, Lab Toxicol & Pharmacocinet Clin, F-31403 Toulouse 4, France
[2] Fac Pharmaceut Sci, Lab Cinet Xenobiot, F-31062 Toulouse, France
[3] Univ Keele, Dept Biol Sci, Keele ST5 5BG, Staffs, England
关键词
P-glycoprotein; everted gut sac; digoxin; verapamil; quinidine;
D O I
10.1016/S0378-5173(98)00225-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein (P-gp) is an energy-dependent transporter protein located in the apical membrane of intestinal mucosal cells. It is believed that it may limit the bioavailability of many orally administered drugs, by transporting them back into the intestinal lumen following their absorption by the enterocytes. To demonstrate the activity of the intestinal P-gp in vitro, we have used the 'improved' rat everted gut sac system, where good tissue viability and metabolic activity is maintained by incubating the everted sacs in tissue culture medium. Digoxin was used as the test drug. After 90 min incubation, its transport across the intestinal mucosa was enhanced 2.5-fold by the P-gp inhibitor verapamil, and 5-fold by the inhibitor quinidine. In the presence of the three drugs, the sacs showed uniform kinetics and good viability, as assessed by the active transport of glucose and lack of release of cellular enzymes. The improved everted gut sac system has potential as a simple and efficient tool to evaluate the role of P-gp in the intestinal absorption of drugs, and to screen for putative P-gp inhibitors that may improve the bioavailability of drugs susceptible to transport by P-gp. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:255 / 258
页数:4
相关论文
共 13 条
[1]  
BARTHE L, 1998, IN PRESS EUR J DRUG
[2]   Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery [J].
Benet, LZ ;
Wu, CY ;
Hebert, MF ;
Wacher, VJ .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :139-143
[3]   Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells [J].
Cavet, ME ;
West, M ;
Simmons, NL .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1389-1396
[4]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[5]   Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery [J].
Hebert, MF .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (2-3) :201-214
[6]  
LEVINE RR, 1970, EUR J PHARMACOL, V1, P211
[7]   AN IMPROVED METHOD FOR ENZYMIC DETERMINATION OF GLUCOSE IN PRESENCE OF MALTOSE [J].
LLOYD, JB ;
WHELAN, WJ .
ANALYTICAL BIOCHEMISTRY, 1969, 30 (03) :467-&
[8]   Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833 [J].
Mayer, U ;
Wagenaar, E ;
Dorobek, B ;
Beijnen, JH ;
Borst, P ;
Schinkel, AH .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2430-2436
[9]  
PETERSON GL, 1983, METHOD ENZYMOL, V91, P95
[10]   A COMPARISON OF THE STRUCTURAL INTEGRITY OF SEVERAL COMMONLY USED PREPARATIONS OF RAT SMALL-INTESTINE INVITRO [J].
PLUMB, JA ;
BURSTON, D ;
BAKER, TG ;
GARDNER, MLG .
CLINICAL SCIENCE, 1987, 73 (01) :53-59